1. Home
  2. SLNO vs EVTC Comparison

SLNO vs EVTC Comparison

Compare SLNO & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • EVTC
  • Stock Information
  • Founded
  • SLNO 1999
  • EVTC 1988
  • Country
  • SLNO United States
  • EVTC United States
  • Employees
  • SLNO N/A
  • EVTC N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EVTC EDP Services
  • Sector
  • SLNO Health Care
  • EVTC Technology
  • Exchange
  • SLNO Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • SLNO 2.3B
  • EVTC 2.0B
  • IPO Year
  • SLNO 2014
  • EVTC 2013
  • Fundamental
  • Price
  • SLNO $69.98
  • EVTC $32.83
  • Analyst Decision
  • SLNO Strong Buy
  • EVTC Hold
  • Analyst Count
  • SLNO 8
  • EVTC 3
  • Target Price
  • SLNO $95.75
  • EVTC $35.67
  • AVG Volume (30 Days)
  • SLNO 2.6M
  • EVTC 305.7K
  • Earning Date
  • SLNO 05-08-2025
  • EVTC 04-30-2025
  • Dividend Yield
  • SLNO N/A
  • EVTC 0.61%
  • EPS Growth
  • SLNO N/A
  • EVTC 42.98
  • EPS
  • SLNO N/A
  • EVTC 1.73
  • Revenue
  • SLNO N/A
  • EVTC $845,486,000.00
  • Revenue This Year
  • SLNO N/A
  • EVTC $7.85
  • Revenue Next Year
  • SLNO N/A
  • EVTC $5.39
  • P/E Ratio
  • SLNO N/A
  • EVTC $18.98
  • Revenue Growth
  • SLNO N/A
  • EVTC 21.70
  • 52 Week Low
  • SLNO $36.61
  • EVTC $28.76
  • 52 Week High
  • SLNO $74.00
  • EVTC $38.87
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 62.10
  • EVTC 38.83
  • Support Level
  • SLNO $57.01
  • EVTC $32.43
  • Resistance Level
  • SLNO $71.00
  • EVTC $33.88
  • Average True Range (ATR)
  • SLNO 5.29
  • EVTC 1.24
  • MACD
  • SLNO -0.08
  • EVTC -0.28
  • Stochastic Oscillator
  • SLNO 76.34
  • EVTC 23.51

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely.

Share on Social Networks: